…ure 1). The type of diabetes predisposing to the development of pancreatic cancer, namely, type 2 diabetes is distinctly different from the diabe…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 241 of 2459…derate for mortality and very low for hospital stay.Conclusions Levosimendan reduced short-term mortality and hospital stay compared with do…
…her conversion rates and faster times to conversion. Therefore, vernakalant is a safe and highly effective intravenous alternative for the …
…Background Diagnosing the presence of metastasis of pancreatic cancer is pivotal for patient management and treatment, with contrast-…
…om patients with CRC.Results EVs derived from highly metastatic CRC cells facilitate the formation of PMNs by driving hepatic lipid…
…veness of the diabetes-related care and education they receive. Diabetes specialist nurses (DSNs) are essential in diabetes care and edu…
… data on mortality from a set of sentinel emergency conditions (paediatric diarrhoea, pneumonia, asthma, diabetic ketoacidosis (DKA), postpartum hae…
…and a ‘cold’ tumor microenvironment (TME).2 We hypothesize that FX-909, an oral first-in-class inhibitor of PPARG, exerts antitumor ac…
…randomised 1:1 to receive either moderate-intensity statin with ezetimibe (rosuvastatin 5 mg with ezetimibe 10 mg) or high-intensity stat…
…ase (FALD) in adulthood. While undergoing routine screening for hepatocellular carcinoma (HCC), both patients had significantly elevated serum alpha-fet…
…nicalTrials.gov between 2014 and 2024 evaluating approved ICIs (nivolumab, pembrolizumab, atezolizumab, durvalumab, avelumab, ipilimumab,…
…icating a higher morbidity. Future directions include comparing melanoma patients treated with ICIs with other sites of metastasis.Abstr…